<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>1373</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>10715528</PubmedId>
            <Abstract>Vaccines containing minigenes - isolated antigenic epitopes encoded by short open reading frames - can, under certain circumstances, confer protective immunity upon the vaccinee. Here we evaluate the efficacy of the minigene vaccine approach using DNA immunization and find that, to be immunogenic, a minigene-encoded epitope requires a perfect "Kozak" translational initiation region. In addition, using intracellular cytokine staining, we show that immunization with a plasmid encoding a full-length protein induces epitope-specific CD8(+) T cells which are detectable directly ex vivo, and constitute approximately 2% of the vaccinee's splenic CD8(+) T cells. In contrast, such cells are undetectable directly ex vivo in recipients of a minigene vaccine. Nevertheless, the minigene plasmid does induce a low number of epitope-specific CD8(+) T cells, which can be amplified to detectable levels by in vivo stimulation. Indeed, 4 days after in vivo stimulation (by virus infection), all vaccinated mice - regardless of whether they had been vaccinated with the minigene or with the full-length gene - had similar numbers of epitope-specific CD8(+) T cells. However, despite these strong responses at 4 days post-infection, recipients of the minigene vaccine showed no enhanced ability to limit virus replication and dissemination. We therefore observe a dichotomy; minigene vaccinees are not protected, despite the presence of strong virus-specific immune responses at 4 days post-challenge. We suggest that the protective benefits of vaccination exert themselves very soon - perhaps within minutes or hours - after virus challenge. If the vaccine-induced immune response is too low to achieve this early protective effect, virus-specific T cells will expand rapidly, but ineffectually, leading to the strong but non-protective response measured at 4 days post-infection. Thus, vaccine-induced immunity should be monitored very early in infection, since the extent to which these responses may later be amplified is largely irrelevant to the protection observed.</Abstract>
            <ArticleYear>2000</ArticleYear>
            <ArticlePages>2132-41</ArticlePages>
            <ArticleTitle>Quantitative and qualitative analyses of the immune responses induced by a multivalent minigene DNA vaccine.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>An</LastName>
                    <ForeName>L L</ForeName>
                </Author>
                <Author>
                    <LastName>Rodriguez</LastName>
                    <ForeName>F</ForeName>
                </Author>
                <Author>
                    <LastName>Harkins</LastName>
                    <ForeName>S</ForeName>
                </Author>
                <Author>
                    <LastName>Zhang</LastName>
                    <ForeName>J</ForeName>
                </Author>
                <Author>
                    <LastName>Whitton</LastName>
                    <ForeName>J L</ForeName>
                </Author>
            </Authors>
            <Affiliations>Department of Neuropharmacology, CVN-9, The Scripps Research Institute, La Jolla, CA 92037, USA.</Affiliations>
            <ArticleChemicalList>Antibodies, Viral;Antigens, Viral;Codon;Cytokines;Epitopes;Vaccines, DNA;Viral Vaccines</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Animals; Antibodies, Viral(biosynthesis; immunology); Antigens, Viral(genetics; immunology); Base Sequence; CD8-Positive T-Lymphocytes(immunology); Codon(genetics); Cytokines(biosynthesis); Epitopes(genetics; immunology); Genes, Synthetic; Immunity, Cellular; Lymphocyte Count; Lymphocytic choriomeningitis virus(genetics; immunology; physiology); Mengovirus(genetics; immunology; physiology); Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Molecular Sequence Data; Open Reading Frames; Plasmids(genetics; immunology); Regulatory Sequences, Nucleic Acid; Respiratory Syncytial Viruses(genetics; immunology); Respirovirus(genetics; immunology); Spleen(immunology); Time Factors; Vaccination; Vaccines, DNA(immunology); Vesicular stomatitis Indiana virus(genetics; immunology); Viral Vaccines(immunology); Virus Replication</ArticleMeshHeadingsList>
            <Journal>
                <Volume>18</Volume>
                <Issue>20</Issue>
                <Title>Vaccine</Title>
                <Issn>0264-410X</Issn>
                <MedlineTa>Vaccine</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>LCMV GP1 33-43</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KAVYNFATCGI</LinearSequence>
                        <StartingPosition>33</StartingPosition>
                        <EndingPosition>43</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P09991.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11624</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 1</LocationOfData>
                <EpitopeId>30005</EpitopeId>
                <ReferenceStartingPosition>33</ReferenceStartingPosition>
                <ReferenceEndingPosition>43</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <TCellId>21570</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000216</OrganismId>
                                <Age>8-12 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P09991.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>11624</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>Mice were boosted twice at two week intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A plasmid encoding the full-length glycoprotein was used for immunization.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>172</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>LCMV GP1 33-43</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KAVYNFATCGI</LinearSequence>
                                        <StartingPosition>33</StartingPosition>
                                        <EndingPosition>43</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P09991.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11624</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>53</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>2.23</QuantitativeMeasurement>
                            <AssayComments>Peptide-specific cells were detectable when mice were immunized with plasmids encoding the full-length glycoprotein. However,  responses were not detected at levels significantly above background after minigene immunization.  When mice were immunized with plasmids encoding the full-length glycoprotein followed by in vivo LCMV restimulation,  the responses were higher.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <TCellId>21569</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000216</OrganismId>
                                <Age>8-12 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>KAVYNFATCGI</LinearSequence>
                                            <StartingPosition>33</StartingPosition>
                                            <EndingPosition>43</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P09991.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11624</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>Mice were boosted twice at two week intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A minigene cassette encoding this and two additional CTL epitopes, two Th epitopes, and one B cell epitope was cloned into the NotI site of plasmid pCMV.  This plasmid was used to immunize mice. .</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>172</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>LCMV GP1 33-43</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KAVYNFATCGI</LinearSequence>
                                        <StartingPosition>33</StartingPosition>
                                        <EndingPosition>43</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P09991.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11624</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>53</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>Peptide-specific cells were not detected at levels significantly above background after minigene immunization.  However, when mice were immunized with plasmids encoding the full-length glycoprotein, the responses were markedly higher.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 7</LocationOfData>
                        <TCellId>21587</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000216</OrganismId>
                                <Age>8-12 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo to prevent or reduce disease</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>KAVYNFATCGI</LinearSequence>
                                            <StartingPosition>33</StartingPosition>
                                            <EndingPosition>43</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P09991.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11624</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>Mice were boosted twice at two week intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A minigene cassette encoding this and two additional CTL epitopes, two Th epitopes, and one B cell epitope was cloned into the NotI site of plasmid pCMV.  This plasmid was used to immunize mice. .</ImmunizationComments>
                        </Immunization>
                        <MhcAllele/>
                        <Antigen>
                            <AntigenReferenceName>Lymphocytic choriomeningitis virus (strain Armstrong)</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Source Organism</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>11624</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>182</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>8</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>Splenic viral titers in immunized mice were not significantly different from the negative controls.  A similar response was seen in the brain tissue after mengovirus challenge.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2A</LocationOfData>
                        <TCellId>21568</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000216</OrganismId>
                                <Age>8-12 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11624</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Lymphocytic choriomeningitis virus (strain Armstrong)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Intramuscular</Route>
                            </FirstInVivoProcess>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellType>Unknown/Unspecified</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                            <AutologousOrSyngeneic>N</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>172</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KAVYNFATCGI</LinearSequence>
                                        <StartingPosition>33</StartingPosition>
                                        <EndingPosition>43</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P09991.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11624</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                            <AntigenContainingObject>
                                <Plasmid>
                                    <SubType>Plasmid</SubType>
                                </Plasmid>
                            </AntigenContainingObject>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>A minigene cassette encoding this and two additional CTL epitopes, two Th epitopes, and one B cell epitope was cloned into the NotI site of plasmid pCMV.  This plasmid was used to transfect K0, an SV-40-transformed cell line.  The minigene-encoded epitopes required a perfect "Kozak" translational initiation region in order to be immunogenic. .</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <TCellId>21583</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000216</OrganismId>
                                <Age>8-12 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>KAVYNFATCGI</LinearSequence>
                                            <StartingPosition>33</StartingPosition>
                                            <EndingPosition>43</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P09991.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11624</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>Mice were boosted twice at two week intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were primed with a minigene cassette encoding this and two additional CTL epitopes, two Th epitopes, and one B cell epitope was cloned into the NotI site of plasmid pCMV.  An in vivo restimulation with LCMV was also administered. .</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>172</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>LCMV GP1 33-43</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KAVYNFATCGI</LinearSequence>
                                        <StartingPosition>33</StartingPosition>
                                        <EndingPosition>43</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P09991.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11624</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>53</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>21.0</QuantitativeMeasurement>
                            <AssayComments>Peptide-specific cells were not detected at levels significantly above background after minigene immunization alone, but were detectable after minigene immunization followed by an in vivo LCMV restimulation.  A similar response was seen in a cytotoxicity assay.  When mice were immunized with plasmids encoding the full-length glycoprotein followed by in vivo LCMV restimulation, the responses were similar.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>RSV M2 82-90</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SYIGSINNI</LinearSequence>
                        <StartingPosition>82</StartingPosition>
                        <EndingPosition>90</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P04545.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11259</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 1</LocationOfData>
                <EpitopeId>62576</EpitopeId>
                <ReferenceStartingPosition>82</ReferenceStartingPosition>
                <ReferenceEndingPosition>90</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2B</LocationOfData>
                        <TCellId>21598</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000216</OrganismId>
                                <Age>8-12 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>SYIGSINNI</LinearSequence>
                                            <StartingPosition>82</StartingPosition>
                                            <EndingPosition>90</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P04545.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11259</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <RecombinantOrganism>
                                        <SubType>Recombinant Organism</SubType>
                                    </RecombinantOrganism>
                                </ImmunogenContainingObject>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>Mice were boosted twice at two week intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were immunized with vaccinia virus carrying this and two additional CTL epitopes, two Th epitopes, and one B cell epitope. .</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Other</CellTissueType>
                            <CellType>L cells-Fibroblast</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                            <AutologousOrSyngeneic>N</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>124</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SYIGSINNI</LinearSequence>
                                        <StartingPosition>82</StartingPosition>
                                        <EndingPosition>90</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P04545.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11259</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                            <AntigenContainingObject>
                                <Plasmid>
                                    <SubType>Plasmid</SubType>
                                </Plasmid>
                            </AntigenContainingObject>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>A minigene cassette encoding this and two additional CTL epitopes, two Th epitopes, and one B cell epitope was cloned into the NotI site of plasmid pCMV.  This plasmid was used to transfect K0, an SV-40-transformed cell line.  The minigene-encoded epitopes required a perfect "Kozak" translational initiation region in order to be immunogenic. .</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 5A</LocationOfData>
                        <TCellId>21601</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000216</OrganismId>
                                <Age>8-12 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>SYIGSINNI</LinearSequence>
                                            <StartingPosition>82</StartingPosition>
                                            <EndingPosition>90</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P04545.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11259</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>Mice were boosted twice at two week intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice were primed with a minigene cassette encoding this and two additional CTL epitopes, two Th epitopes, and one B cell epitope was cloned into the NotI site of plasmid pCMV.  An in vivo restimulation with Respiratory syncytial virus was also administered. .</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Other</CellTissueType>
                            <CellType>L cells-Fibroblast</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>124</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>RSV M2 82-90</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SYIGSINNI</LinearSequence>
                                        <StartingPosition>82</StartingPosition>
                                        <EndingPosition>90</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P04545.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11259</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The response to the virus was accelerated and enhanced as a result of minigene priming.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>SV NP 324-332</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>FAPGNYPAL</LinearSequence>
                        <StartingPosition>324</StartingPosition>
                        <EndingPosition>332</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P04857.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11194</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 1</LocationOfData>
                <EpitopeId>15248</EpitopeId>
                <ReferenceStartingPosition>324</ReferenceStartingPosition>
                <ReferenceEndingPosition>332</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 5B</LocationOfData>
                        <TCellId>21605</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000216</OrganismId>
                                <Age>8-12 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>FAPGNYPAL</LinearSequence>
                                            <StartingPosition>324</StartingPosition>
                                            <EndingPosition>332</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P04857.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11194</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>Mice were boosted twice at two week intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>T cell CD8+</ResponderCellType>
                                <StimulatorCellType>Splenocyte</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>FAPGNYPAL</LinearSequence>
                                            <StartingPosition>324</StartingPosition>
                                            <EndingPosition>332</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P04857.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11194</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Mice were primed with a minigene cassette encoding this and two additional CTL epitopes, two Th epitopes, and one B cell epitope was cloned into the NotI site of plasmid pCMV.  An in vivo restimulation with Sendai virus was also adminitered.  Splenocytes were restimulated in vitro for 4 days in the presence of the Sendai virus peptide FAPGNYPAL. .</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell CD8+</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellType>Unknown/Unspecified</CellType>
                            <CellCultureConditions>Cell Line / Clone</CellCultureConditions>
                            <AutologousOrSyngeneic>Y</AutologousOrSyngeneic>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>124</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>SV NP 324-332</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>FAPGNYPAL</LinearSequence>
                                        <StartingPosition>324</StartingPosition>
                                        <EndingPosition>332</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P04857.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11194</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The target cells were K0, an SV-40-transformed cell line.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>VSV GP 415-433</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SSKAQVFEHPHIQDAASQ</LinearSequence>
                        <StartingPosition>415</StartingPosition>
                        <EndingPosition>432</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P04884.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11284</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 1</LocationOfData>
                <EpitopeId>61130</EpitopeId>
                <ReferenceStartingPosition>415</ReferenceStartingPosition>
                <ReferenceEndingPosition>432</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 6</LocationOfData>
                        <TCellId>21740</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000216</OrganismId>
                                <Age>8-12 weeks-old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>SSKAQVFEHPHIQDAASQ</LinearSequence>
                                            <StartingPosition>415</StartingPosition>
                                            <EndingPosition>432</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P04884.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>11284</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>VSV GP 415-433</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <Plasmid>
                                        <SubType>Plasmid</SubType>
                                    </Plasmid>
                                </ImmunogenContainingObject>
                                <Route>Intramuscular</Route>
                                <DoseSchedule>Mice were boosted twice.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>A minigene cassette encoding three CTL epitopes, two Th epitopes (including this epitope), and one B cell epitope was cloned into the NotI site of plasmid pCMV.  This plasmid was used to immunize mice.  Six weeks later, mice were infected with Vesicular stomatitis virus. .</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellType>T cell CD4+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <MhcAllele>
                            <MhcAlleleId>181</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>Vesicular stomatitis virus (strain Orsay)</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Source Organism</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>11284</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>269</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The assay examined the ability a T helper epitope to enhance the virus-specific neutralizing antibody response.  Although antibodies were detected, no significant enhancement of anti-virus antibodies over control levels was detected.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

